Gabapentin for Bipolar & Cannabis Use Disorders

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

July 1, 2019

Study Completion Date

July 1, 2019

Conditions

Bipolar I DisorderBipolar II DisorderCannabis Use DisorderSubstance Use Disorders

Interventions

DRUG

Gabapentin

5 day trial of gabapentin with titration to 1,200mg

DRUG

Placebo Oral Capsule

5 day trial of matched placebo

Trial Locations (1)

Medical University of South Carolina, Charleston

All Listed Sponsors

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Medical University of South Carolina

OTHER

NCT03334721 - Gabapentin for Bipolar & Cannabis Use Disorders | Biotech Hunter | Biotech Hunter